Hi K***e, I’m J***e, an HR Recruiter at StrategyBrain partnering with N***h D***l. I came across your profile and was really impressed by your track record at M***t,especially driving AI-powered cloud and conversational solutions in healthcare and consistently exceeding quotas. We’re currently looking for a Regional Sales Director, Healthcare & Life Sciences Digital Solutions for the DACH region. With your deep sector expertise and strong leadership in go-to-market strategies, I believe this role could be a great match. Would you be open to a brief chat to explore this opportunity further? Best regards, J***e

Hi K***e, Great to hear you’re interested. Here’s a quick overview of the Regional Sales Director role at N***h D***l and how it aligns with your experience: • Company & Mission: N***h D***l is a Munich-based leader in secure, AI-powered cloud and conversational solutions for hospitals, pharma and research institutes. We’re on a mission to drive measurable clinical and financial impact through digital transformation. • Role Highlights: , You’ll develop and execute go-to-market strategies for our Healthcare & Life Sciences Digital Solutions across DACH,exactly the space where you’ve excelled at M***t and N***e. , You’ll build, mentor and scale a high-performing sales team to generate pipeline, close new business, drive upsells and secure renewals. , You’ll cultivate executive relationships with hospital IT, KIS vendors, pharma decision-makers and government bodies,leveraging your existing network and regulatory know-how (DSGVO, KHZG, EHDS). , You’ll partner with marketing, product and channel teams to refine positioning, run targeted campaigns and optimize our sales motion. • What’s in It for You: , A strategic, visible role in shaping N***h D***l’s healthcare agenda and scaling our regional footprint. , Clear career path toward VP Sales or Head of DACH, supported by tailored leadership development programs. , Best-in-class enablement: salesforce automation, marketing resources, dedicated solution architects and competitive compensation with bonus and equity upside. Does this sound like the kind of challenge you’re looking for? I’d love to walk you through more details and learn about your goals. Would you be available for a 30-minute call? I’m free: • Tomorrow (Wednesday) 9:00,11:00 AM CET • Thursday 3:00,5:00 PM CET Let me know which slot works for you,or feel free to suggest another time. I look forward to speaking soon! Best regards, J***e HR Recruiter, StrategyBrain / N***h D***l

Hi K***e, Glad Thursday 3,5 PM CET works for you. To give you a snapshot before our call: • Current team size: , You’ll partner with two Senior Account Executives (one focused on hospitals/KIS vendors, one on pharma & life sciences) and a Solutions Consultant. , Our plan is for you to recruit and onboard another 3,4 quota-carrying reps within your first 9,12 months, plus a dedicated sales operations specialist. • Primary growth targets: , Year 1 bookings quota: USD 12 million (new logo & upsells). , Pipeline generation goal: USD 20 million+. , By Year 2, we’re targeting USD 18 million+ in closed business, with continued team ramp and a 50% YoY growth trajectory. We’ll dive deeper into headcount plans, hiring cadence and market nuances on Thursday. Looking forward to our conversation! Best, J***e

Hi K***e, Great questions,here’s a preliminary breakdown and ramp plan: 1. Quota Split (Year 1, $12 M) • Net-new logos: ~70% (~$8.4 M) • Upsells/expansions: ~30% (~$3.6 M) 2. Current Pipeline Coverage Our DACH healthcare pipeline today sits at roughly 2,2.5× quota (~$25,30 M), with healthy early-stage motion in both hospital/KIS and pharma segments. We’re actively accelerating lead generation to ensure you hit your $20 M+ pipeline goal by quarter two. 3. Ramp & Enablement Support • Hiring cadence: You’ll onboard 3,4 new AEs over months 1,9, alongside a dedicated Sales Ops specialist. • Structured ramp: A 90-day onboarding program with product deep dives, joint calls with our Solutions Consultant, live demos and shadow days with senior reps. • Ops & tooling: Full Salesforce CRM support, custom dashboards, deal‐review cadence and data analytics from day one. • Enablement: Bi-weekly training sessions (product updates, objection handling, competitive playbooks), hands-on workshops with our marketing team for campaign alignment, plus dedicated solution architects to co-sell on complex deals. • Ongoing coaching: Weekly 1:1s with you, monthly leadership forums and quarterly offsites to share best practices across the global N***h D***l sales organization. All of this is designed to set your team,and you,up to exceed 50% YoY growth. Happy to dive deeper on any point during our call! Looking forward to it. Best, J***e

Hi K***e, Happy to break this down: 1. Pipeline by segment & stage - Hospitals & KIS vendors: ~60% of the $25,30 M pipeline (≈ $15,18 M) • Stage 1 (Qualification & discovery): 30% • Stage 2 (Solution demos & workshops): 35% • Stage 3 (Pilot/proof of concept): 25% • Stage 4 (Negotiation & contracting): 10% - Pharma & life sciences: ~40% of the pipeline (≈ $10,12 M) • Stage 1: 35% • Stage 2: 30% • Stage 3: 25% • Stage 4: 10% We’re entering most of these deals at Stage 1,2, with solid qualification in both segments and pilots kicking off over the next 4,8 weeks. 2. AE ramp to quota (month-by-month) • Month 1: Onboarding & joint calls (0,5% of quota) • Month 2: Early pipeline engagement (10,15%) • Month 3: Own-prospecting begins (25%) • Month 4: Driving qualified opportunities (40%) • Month 5: Managing mid-funnel deals (60%) • Month 6: Full quota attainment target (80,100%) • Months 7,9: Sustained 100%+ run-rate 3. Solution Architect involvement , From Day 1 your SA will co-host discovery sessions and deep-dive demos. , They’ll join 100% of technical workshops, pilot scoping calls and executive reviews. , We run weekly deal reviews with AEs + SA + you, so each early deal has both sales and solution expertise baked in. Let me know if you’d like any additional color ahead of our call. Looking forward to walking through this on Thursday! Best, J***e

Hi K***e, Happy to share more detail: 1. Average deal size & typical sales cycle • Hospitals & KIS vendors , Avg deal size: USD 700,900 K , Sales cycle: 9,12 months (from initial discovery to close) • Pharma & Life Sciences , Avg deal size: USD 400,600 K , Sales cycle: 6,9 months 2. Marketing & lead-gen conversion benchmarks • Digital campaigns (email, LinkedIn ads) , Click-to-MQL: ~4,6% , MQL-to-SQL: ~25% • Webinars & virtual events , Registration-to-attendee: ~60% , Attendee-to-MQL: ~20,30% • Partner/referral leads , Referral-to-SQL: ~50% • Overall funnel efficiency , Lead to opportunity conversion: ~10,12% , Opportunity to closed-won: ~18,22% These programs currently feed about 30,35% of our active pipeline, with the rest coming from outbound and executive referrals. We’ll be diving into the channel mix and upcoming campaign calendar on Thursday,looking forward to your thoughts! Best regards, J***e

Hi K***e, Here’s a high-level view: 1. Lead-gen channels & win rates • Partner/Referral leads , highest win rate (referral→SQL ~50%, opp→close ~20,22%) • Webinars/Virtual events , solid performance (attendee→MQL ~20,30%, opp→close ~18,20%) • Digital campaigns (email, paid social) , more volume but lower win rate (click→MQL ~4,6%, MQL→SQL ~25%, opp→close ~10,12%) 2. Average CAC • Across our enterprise healthcare deals, average CAC sits in the high-four to low-five-figure range per closed deal. • Digital campaigns skew toward the higher end of that range, webinars/events mid-range, and partner/referral leads at the lower end. 3. Segment differences • Hospitals & KIS vendors , Sales cycle: 9,12 months , Win rate: ~18,20% , CAC: modestly higher due to lengthy pilot/exec-review phases • Pharma & Life Sciences , Sales cycle: 6,9 months , Win rate: ~20,25% , CAC: 10,15% lower on average, thanks to faster validation and streamlined procurement Happy to dive deeper on these figures and explore channel mix strategies when we speak on Thursday. Looking forward to it! Best, J***e